Literature DB >> 22944482

Serum cathelicidin level is associated with viral etiology and severity of bronchiolitis.

Jonathan M Mansbach, Pedro A Piedra, Niels Borregaard, Adrian R Martineau, Mark I Neuman, Janice A Espinola, Carlos A Camargo.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22944482      PMCID： PMC3462235          DOI： 10.1016/j.jaci.2012.07.044

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN： 0091-6749            Impact factor:   10.793


× No keyword cloud information.
  8 in total

1.  Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response.

Authors:  Philip T Liu; Steffen Stenger; Huiying Li; Linda Wenzel; Belinda H Tan; Stephan R Krutzik; Maria Teresa Ochoa; Jürgen Schauber; Kent Wu; Christoph Meinken; Diane L Kamen; Manfred Wagner; Robert Bals; Andreas Steinmeyer; Ulrich Zügel; Richard L Gallo; David Eisenberg; Martin Hewison; Bruce W Hollis; John S Adams; Barry R Bloom; Robert L Modlin
Journal:  Science       Date:  2006-02-23       Impact factor: 47.728

2.  Prospective multicenter study of viral etiology and hospital length of stay in children with severe bronchiolitis.

Authors:  Jonathan M Mansbach; Pedro A Piedra; Stephen J Teach; Ashley F Sullivan; Tate Forgey; Sunday Clark; Janice A Espinola; Carlos A Camargo
Journal:  Arch Pediatr Adolesc Med       Date:  2012-08

3.  Diagnosis and management of bronchiolitis.

Authors: 
Journal:  Pediatrics       Date:  2006-10       Impact factor: 7.124

4.  Circulating levels of 25-hydroxyvitamin D and human cathelicidin in healthy adults.

Authors:  Ishir Bhan; Carlos A Camargo; Julia Wenger; Catherine Ricciardi; Jun Ye; Niels Borregaard; Ravi Thadhani
Journal:  J Allergy Clin Immunol       Date:  2011-02-09       Impact factor: 10.793

5.  Vitamin D, innate immunity and outcomes in community acquired pneumonia.

Authors:  Leong Leow; Talia Simpson; Ray Cursons; Noel Karalus; Robert J Hancox
Journal:  Respirology       Date:  2011-05       Impact factor: 6.424

Review 6.  Unexpected actions of vitamin D: new perspectives on the regulation of innate and adaptive immunity.

Authors:  John S Adams; Martin Hewison
Journal:  Nat Clin Pract Endocrinol Metab       Date:  2008-02

7.  Low plasma level of cathelicidin antimicrobial peptide (hCAP18) predicts increased infectious disease mortality in patients undergoing hemodialysis.

Authors:  Adrian F Gombart; Ishir Bhan; Niels Borregaard; Hector Tamez; Carlos A Camargo; H Phillip Koeffler; Ravi Thadhani
Journal:  Clin Infect Dis       Date:  2009-02-15       Impact factor: 9.079

Review 8.  Vitamin D, innate immunity and upper respiratory tract infection.

Authors:  J Bartley
Journal:  J Laryngol Otol       Date:  2010-01-13       Impact factor: 1.469
  8 in total
  20 in total

1.  Circulating 25-hydroxyvitamin D, nasopharyngeal airway metabolome, and bronchiolitis severity.

Authors:  K Hasegawa; C J Stewart; J C Celedón; J M Mansbach; C Tierney; C A Camargo
Journal:  Allergy       Date:  2018-02-05       Impact factor: 13.146

2.  Serum cathelicidin, nasopharyngeal microbiota, and disease severity among infants hospitalized with bronchiolitis.

Authors:  Kohei Hasegawa; Jonathan M Mansbach; Nadim J Ajami; Joseph F Petrosino; Robert J Freishtat; Stephen J Teach; Pedro A Piedra; Carlos A Camargo
Journal:  J Allergy Clin Immunol       Date:  2016-11-12       Impact factor: 10.793

3.  Low Retinol-Binding Protein and Vitamin D Levels Are Associated with Severe Outcomes in Children Hospitalized with Lower Respiratory Tract Infection and Respiratory Syncytial Virus or Human Metapneumovirus Detection.

Authors:  Julia L Hurwitz; Bart G Jones; Rhiannon R Penkert; Shane Gansebom; Yilun Sun; Li Tang; Anna M Bramley; Seema Jain; Jonathan A McCullers; Sandra R Arnold
Journal:  J Pediatr       Date:  2017-05-31       Impact factor: 4.406

4.  Low serum 25-hydroxyvitamin D levels and bronchiolitis severity in Spanish infants.

Authors:  Gloria Moreno-Solís; Fernando Fernández-Gutiérrez; Javier Torres-Borrego; Ricardo Torcello-Gáspar; José Luis Gómez-Chaparro Moreno; Juan Luis Pérez-Navero
Journal:  Eur J Pediatr       Date:  2014-09-02       Impact factor: 3.183

5.  Vitamin D Levels Are Unrelated to the Severity of Respiratory Syncytial Virus Bronchiolitis Among Hospitalized Infants.

Authors:  Avraham Beigelman; Mario Castro; Toni L Schweiger; Brad S Wilson; Jie Zheng; Huiquing Yin-DeClue; Geneline Sajol; Tusar Giri; Oscar L Sierra; Megan Isaacson-Schmid; Kaharu Sumino; Kenneth B Schechtman; Leonard B Bacharier
Journal:  J Pediatric Infect Dis Soc       Date:  2014-06-05       Impact factor: 3.164

6.  Severe bronchiolitis profiles and risk of recurrent wheeze by age 3 years.

Authors:  Orianne Dumas; Kohei Hasegawa; Jonathan M Mansbach; Ashley F Sullivan; Pedro A Piedra; Carlos A Camargo
Journal:  J Allergy Clin Immunol       Date:  2018-09-18       Impact factor: 10.793

Review 7.  The role of vitamin D in prevention and treatment of infection.

Authors:  Cameron F Gunville; Peter M Mourani; Adit A Ginde
Journal:  Inflamm Allergy Drug Targets       Date:  2013-08

8.  Serum LL-37 Levels Associated With Severity of Bronchiolitis and Viral Etiology.

Authors:  Jonathan M Mansbach; Kohei Hasegawa; Nadim J Ajami; Joseph F Petrosino; Pedro A Piedra; Courtney N Tierney; Janice A Espinola; Carlos A Camargo
Journal:  Clin Infect Dis       Date:  2017-09-15       Impact factor: 9.079

9.  The human cathelicidin LL-37 has antiviral activity against respiratory syncytial virus.

Authors:  Silke M Currie; Emily Gwyer Findlay; Brian J McHugh; Annie Mackellar; Tian Man; Derek Macmillan; Hongwei Wang; Paul M Fitch; Jürgen Schwarze; Donald J Davidson
Journal:  PLoS One       Date:  2013-08-30       Impact factor: 3.240

Review 10.  Cationic host defence peptides: potential as antiviral therapeutics.

Authors:  Emily Gwyer Findlay; Silke M Currie; Donald J Davidson
Journal:  BioDrugs       Date:  2013-10       Impact factor: 5.807
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.